Tick-Borne Disease Alliance

Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square

Retrieved on: 
Tuesday, October 17, 2023
Lyme disease, Social media, PSA, Heart, Hope, Family, Chronic Lyme disease, Times Square, Judgement, GLA, Dream, Partnership, Tick-Borne Disease Alliance, QuidelOrtho, Poultry farming

STAMFORD, Conn., Oct. 17, 2023 /PRNewswire/ -- In an inspiring and emotional display of solidarity for Lyme disease awareness, a striking public service announcement (PSA) has taken center stage in the heart of New York City's Times Square. The PSA, is a poignant call to action, shedding light on chronic Lyme disease.

Key Points: 
  • The PSA, is a poignant call to action, shedding light on chronic Lyme disease.
  • Directed by Erich Bergen, the PSA features Global Lyme Alliance (GLA) celebrity ambassador and actor Christopher Meloni, whose family has been impacted by Lyme disease.
  • The decision to feature the PSA in Times Square reflects a collective effort to bring awareness to chronic Lyme disease.
  • "We hope this PSA will serve as a tool to bring awareness to the often underestimated magnitude of Lyme disease.

Lyme Disease Most Common in the Age Group 51-60 in the Period 2018-2022

Retrieved on: 
Tuesday, October 17, 2023
FAIR, Lyme disease, Prevalence, Ageing, Health, Disease, Tick-Borne Disease Alliance, Fatigue, Patient, Medical imaging

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- In the period 2018-2022, more Lyme disease claim lines were filed for individuals in the 51-60 age group than any other group, according to an infographic based on private insurance claims and released today by FAIR Health.1 Individuals aged 51 to 60 accounted for 23.5 percent of Lyme disease claim lines, compared to 18.8 percent in the next largest age group, 41-50. The remaining age groups studied, with their percentages of Lyme disease claim lines, were 31-40 (14.1 percent), 19-30 (14.0 percent), 61-70 (13.9 percent), 0-18 (11.3 percent) and over 70 (4.3 percent).

Key Points: 
  • The remaining age groups studied, with their percentages of Lyme disease claim lines, were 31-40 (14.1 percent), 19-30 (14.0 percent), 61-70 (13.9 percent), 0-18 (11.3 percent) and over 70 (4.3 percent).
  • From 2018 to 2022, claim lines with Lyme disease diagnoses peaked nationally in June and July of each year.
  • During these summer months, rural areas, on average, had a greater share of claim lines associated with Lyme disease diagnoses than urban areas.
  • From November to April, however, claim lines with Lyme disease diagnoses occurred more often in urban than rural areas.

Christopher Meloni, Celebrity Ambassador for the Global Lyme Alliance, invites you to be a hero!

Retrieved on: 
Thursday, August 31, 2023
Hero, Tick-Borne Disease Alliance, Copper, Notifiable disease, Lyme disease, Vaccine

MOUNT KISCO, N.Y. , Aug. 31, 2023 /PRNewswire/ -- Christopher Meloni is using a new "Hero" product from Tommie Copper to help raise money for the Global Lyme Alliance.

Key Points: 
  • MOUNT KISCO, N.Y. , Aug. 31, 2023 /PRNewswire/ -- Christopher Meloni is using a new "Hero" product from Tommie Copper to help raise money for the Global Lyme Alliance.
  • From August 31 - September 7, 5% of all sales from Tommie Copper's new "Hero" product will be donated to the Global Lyme Alliance.
  • And now, it's partnering with the Global Lyme Alliance in their fight against Lyme and other tick-borne diseases, donating 5% of sales from this new "Hero" product between August 31 - September 7.
  • Join us in the fight against Lyme disease and you'll know what it's like to be a hero.

EVERSANA INTOUCH Wins Five Clio Awards

Retrieved on: 
Monday, June 5, 2023
Pupa, Advertising, Music, Clio, Muses, Clio Awards, Silver, Tick-Borne Disease Alliance, Creativity, Gold, Poster, Cannabis, Sport, Phylogenetic inference using transcriptomic data, Photography, Mental Health Awareness Month, Health

CHICAGO, June 5, 2023 /PRNewswire/ -- EVERSANA , a leading provider of commercial services to the global life sciences industry, today announced that its agency network, EVERSANA INTOUCH , has been named a five-category winner at the 2023 Clio Health Awards .

Key Points: 
  • CHICAGO, June 5, 2023 /PRNewswire/ -- EVERSANA , a leading provider of commercial services to the global life sciences industry, today announced that its agency network, EVERSANA INTOUCH , has been named a five-category winner at the 2023 Clio Health Awards .
  • The team earned one gold, one silver, and three bronze awards for work with The Chrysalis Initiative and the Global Lyme Alliance.
  • "What a tremendous achievement to be recognized across multiple categories at the Clio Awards," said Jim Lang, CEO, EVERSANA.
  • Annually, The Clio Awards bring together leading creative talent for an exclusive and collaborative judging experience to select the entries for the coveted Clio statues.

USDA Approves Novel Vaccine Against Wildlife Spread of the Bacterium Responsible for Lyme Disease

Retrieved on: 
Tuesday, May 9, 2023
Infection, Yale University, Disease, University, Lyme disease, University of Tennessee Health Science Center, Lyme, Management, Borrelia burgdorferi, Tick-Borne Disease Alliance, Connecticut Agricultural Experiment Station, Golf, CDC, Cary Institute of Ecosystem Studies, Notifiable disease, USDA, Risk, CAES, Safety, Vaccine, Pharmaceutical industry

MEMPHIS, Tenn., May 9, 2023 /PRNewswire/ -- US Biologic, Inc. , a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announces USDA Conditional Licensure of its novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, the number one vector-borne disease in the U.S.

Key Points: 
  • MEMPHIS, Tenn., May 9, 2023 /PRNewswire/ -- US Biologic, Inc. , a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announces USDA Conditional Licensure of its novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, the number one vector-borne disease in the U.S.
  • The only known vector is the blacklegged tick, which is infected primarily by feeding on small wildlife mammals, particularly white-footed mice.
  • The vaccine, called "Borrelia Burgdorferi Bacterin," is spray-coated onto pellets that the mice consume.
  • "Our team members, our leadership, and our partners are dedicated to disease prevention," says US Biologic Chief Executive Officer Mason Kauffman.

Bay Area Lyme Foundation Celebrates Department of Defense CDMRP Tick-borne Disease Awardees

Retrieved on: 
Thursday, March 23, 2023
Columbia University, Tufts University, Duke University, Biobank, Notifiable disease, Doctor of Pharmacy, Virginia Tech, Therapy, Lyme disease, Babesiosis, Frontiers, Gastrointestinal tract, Infection, COVID-19, DNA sequencing, AGS, Immunoglobulin M, PCR, MBA, Research, Immunoglobulin A, Tick, Antibody, Peptidoglycan, Veteran, Tick-Borne Disease Alliance, Johns Hopkins University, Blood transfusion, Patient, Risk, Blood, Immunoglobulin G, DVM, NIH, MBI, Skin, Vaccine, Microbiology, Doctor of Philosophy, MD

PORTOLA VALLEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the US, announces that two projects it has previously funded have now received Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Tick-Borne Disease awards.

Key Points: 
  • PORTOLA VALLEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the US, announces that two projects it has previously funded have now received Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Tick-Borne Disease awards.
  • Three of the six recently announced CDMRP awardees will be using biological samples from Bay Area Lyme Foundation’s Lyme Disease Biobank to enable their research into diagnostics and therapeutics for tick-borne diseases, including Lyme disease—which infects half a million people each year.
  • Peter Gwynne, research assistant professor in Hu's lab, was a Bay Area Lyme Foundation ELA winner in 2022 and has used samples from the Lyme Disease Biobank.
  • Jutras was a Bay Area Lyme Foundation ELA winner in 2021 and his lab will be using samples from the Lyme Biobank to validate their novel diagnostics.

EQS-News: Development of New Drugs to Target Lyme and Other Infectious Diseases Subject of a New Webinar Now Available From Quidel Corporation

Retrieved on: 
Tuesday, October 4, 2022
Duke University School of Medicine, Howard Hughes Medical Institute, Tick-Borne Disease Alliance, Cancer, Physician, Obesity, Nasdaq, Research, School of Life Sciences (University of Dundee), Privacy, Prevalence, Blood, FDA, Infection, COVID-19, Borrelia burgdorferi, Method, University of Washington, Patient, Hypertension, University, Pharmacology, Vaccine, Pharmaceutical industry, Lyme disease, Quidel Corporation

It will also provide an overview as to the current antibiotics used for treating Lyme disease and explore how powerful new drugsnovel inhibitorscan selectively target Borrelia burgdorferi (the bacterium that causes Lyme disease).

Key Points: 
  • It will also provide an overview as to the current antibiotics used for treating Lyme disease and explore how powerful new drugsnovel inhibitorscan selectively target Borrelia burgdorferi (the bacterium that causes Lyme disease).
  • The webinar is PACE-accredited and sponsored in collaboration with Global Lyme Alliance.
  • Conducting the webinar is Timothy Haystead, Ph.D., professor of pharmacology and cancer biology at Duke University School of Medicine.
  • Quidel is the diagnostic health care manufacturer behind the industrys most rapid and reliable in-office test for Lyme disease, Sofia 2 Lyme FIA.

Development of New Drugs to Target Lyme and Other Infectious Diseases Subject of a New Webinar Now Available From Quidel Corporation

Retrieved on: 
Tuesday, October 4, 2022
Health, Infectious Diseases, Hospitals, Managed Care, General Health, Pharmaceutical, Biotechnology, Duke University School of Medicine, Howard Hughes Medical Institute, Tick-Borne Disease Alliance, Cancer, Physician, Obesity, Nasdaq, Research, School of Life Sciences (University of Dundee), Privacy, Prevalence, Blood, FDA, COVID-19, Infection, Borrelia burgdorferi, Method, University of Washington, Patient, Hypertension, University, Pharmacology, Vaccine, Pharmaceutical industry, Lyme disease, Quidel Corporation

It will also provide an overview as to the current antibiotics used for treating Lyme disease and explore how powerful new drugsnovel inhibitorscan selectively target Borrelia burgdorferi (the bacterium that causes Lyme disease).

Key Points: 
  • It will also provide an overview as to the current antibiotics used for treating Lyme disease and explore how powerful new drugsnovel inhibitorscan selectively target Borrelia burgdorferi (the bacterium that causes Lyme disease).
  • The webinar is PACE-accredited and sponsored in collaboration with Global Lyme Alliance.
  • Conducting the webinar is Timothy Haystead, Ph.D., professor of pharmacology and cancer biology at Duke University School of Medicine.
  • Quidel is the diagnostic health care manufacturer behind the industrys most rapid and reliable in-office test for Lyme disease, Sofia 2 Lyme FIA.

EVERSANA INTOUCH Wins Agency of the Year, Faruk Capan Named Advertising Agency CEO of the Year in PM360 Trailblazer Awards

Retrieved on: 
Friday, September 23, 2022
Slate, Online, Tick-Borne Disease Alliance, Definity, New product development, Proto, Oxygen, Twitter, Luka Capan, Social responsibility, Advertising, Organization, LinkedIn, Advertising agency, Achievement, Industry, Patient, CEO, Instagram, Line, Solution, Multimedia, Pharmaceutical industry, Satellite navigation device, Public relations, Sales, Facebook

KANSAS CITY, Kan., Sept. 23, 2022 /PRNewswire/ -- EVERSANA , a pioneer of next-generation commercial services to the global life sciences industry, today announced that EVERSANA INTOUCH was awarded the 2022 Advertising Agency of the Year, and Chief Executive Officer (CEO) Faruk Capan was named Advertising Agency CEO of the Year at the 2022 PM360 Trailblazer Awards.

Key Points: 
  • KANSAS CITY, Kan., Sept. 23, 2022 /PRNewswire/ -- EVERSANA , a pioneer of next-generation commercial services to the global life sciences industry, today announced that EVERSANA INTOUCH was awarded the 2022 Advertising Agency of the Year, and Chief Executive Officer (CEO) Faruk Capan was named Advertising Agency CEO of the Year at the 2022 PM360 Trailblazer Awards.
  • Capan founded the agency in 1999 and today, the multi-affiliate agency network includes more than 1,800 employees across more than 40 locations worldwide.
  • "While our 'day job' is focused on delighting our clients and promoting their brands, today we take a moment to honor the entire EVERSANA INTOUCH team, and my friend Faruk Capan," said Jim Lang, CEO, EVERSANA.
  • EVERSANA INTOUCH provides marketing services connected and powered by data-rich, digitally-forward analytics through its affiliates: EVERSANA INTOUCH Solutions, EVERSANA INTOUCH Proto, EVERSANA INTOUCH Seven, EVERSANA INTOUCH Oxygen, EVERSANA INTOUCH Engage, EVERSANA INTOUCH B2B, EVERSANA INTOUCH Media, and EVERSANA INTOUCH International.

Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation

Retrieved on: 
Wednesday, August 24, 2022
Technology, Infectious Diseases, Hospitals, Software, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Nervous system, COVID-19, University, Human, Exocrine gland, Mucus, Tick-Borne Disease Alliance, Biofilm, Disease, Virulence, Heart, National, Infection, Blood, Point-of-care testing, Tick-borne disease, Physician, Skin, Diagnosis, Degenerative disease, Time-invariant system, Laboratory, Gastrointestinal tract, Cystic fibrosis, Joint, Privacy, Nasdaq, FDA, Prevalence, Chronic Lyme disease, Â, Environment, Bacteria, Patient, Vaccine, Quidel Corporation, Lyme disease

This important medical reality is now being addressed in a new webinar made available by Quidel Corporation, the California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions.

Key Points: 
  • This important medical reality is now being addressed in a new webinar made available by Quidel Corporation, the California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions.
  • The webinar, available at https://education.quidel.com/educational-categories , discusses the basics of bacterial biofilms including when and how they develop, its composition and factors that contribute to antibiotic resistance and virulence.
  • The session also explores the biofilms in the context of Lyme disease and the potential link between chronic Lyme and biofilm formation.
  • It is important to understand how these biofilms are formed and their maturation as well as their dispersal.